The other brain: From dementia to schizophrenia, how new discoveries about the brain are revolutionizing medicine and science

le Heneka, Michael T.
Foilsithe 2010

Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction

le Heneka, Michael T.
Foilsithe 2014

Inflammasome activation and innate immunity in Alzheimer's disease

le Heneka, Michael T.
Foilsithe in Brain Pathol (2017)

Microglia in Alzheimer’s disease

le Sarlus, Heela, Heneka, Michael T.
Foilsithe in J Clin Invest (2017)

Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration

le Ising, Christina, Heneka, Michael T.
Foilsithe in Cell Death Dis (2018)

Microglia in Alzheimer’s disease: Local heroes!

le Villacampa, Nàdia, Heneka, Michael T.
Foilsithe in J Exp Med (2020)

PPARs in Alzheimer's Disease

le Kummer, Markus P., Heneka, Michael T.
Foilsithe 2008

Truncated and modified amyloid-beta species

le Kummer, Markus P, Heneka, Michael T
Foilsithe 2014

Screening for Niemann-Pick Type C Disease in a Memory Clinic Cohort

le Traschütz, Andreas, Heneka, Michael Thomas
Foilsithe in JIMD Rep (2018)

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors

le Tatenhorst, Lars, Hahnen, Eric, Heneka, Michael T.
Foilsithe 2008

Role of neuroinflammation in neurodegeneration: new insights

le McManus, Róisín M., Heneka, Michael T.
Foilsithe in Alzheimers Res Ther (2017)

Personalized genetics of the cholinergic blockade of neuroinflammation

le Simchovitz, Alon, Heneka, Michael T., Soreq, Hermona
Foilsithe in J Neurochem (2017)

Peroxisome Proliferator-Activated Receptor-γ Ligands Reduce Neuronal Inducible Nitric Oxide Synthase Expression and Cell DeathIn Vivo

le Heneka, Michael T., Klockgether, Thomas, Feinstein, Douglas L.
Foilsithe in J Neurosci (2000)

PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease

le Landreth, Gary, Jiang, Qingguang, Mandrekar, Shweta, Heneka, Michael
Foilsithe 2008

Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

le Brosseron, Frederic, Krauthausen, Marius, Kummer, Markus, Heneka, Michael T.
Foilsithe 2014

Time course of dementia following sepsis in German health claims data

le Fritze, Thomas, Doblhammer, Gabriele, Widmann, Catherine N., Heneka, Michael T.
Foilsithe in Neurol Neuroimmunol Neuroinflamm (2020)

Impact and Therapeutic Potential of PPARs in Alzheimer's Disease

le Heneka, Michael T, Reyes-Irisarri, Elisabet, Hüll, Michael, Kummer, Markus P
Foilsithe 2011

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

le Heneka, Michael T., Golenbock, Douglas, Latz, Eicke, Morgan, Dave, Brown, Robert
Foilsithe in Alzheimers Res Ther (2020)

Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients

le Okroglic, Sandra, Widmann, Catherine N., Urbach, Horst, Scheltens, Philip, Heneka, Michael T.
Foilsithe 2013

CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system

le Krauthausen, Marius, Saxe, Simon, Zimmermann, Julian, Emrich, Michael, Heneka, Michael T, Müller, Marcus
Foilsithe 2014